RxDoctor Payments Data

Randy Gubler

Foot & Ankle Surgery · Las Vegas, NVNPI 1679587612

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Goode Surgical Inc at 48.4% of the total. Reporting peaked in 2019 at $3,723 and has fallen 87.5% since, to $464 in 2025.

$7,582in general payments, 2019–2025

Across 190 payments — averaging $39.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Goode Surgical Inc$4K
  • Treace Medical Concepts, Inc.$1K
  • Smith+Nephew$469
  • AbbVie$275
  • Paratek Pharmaceuticals, Inc.$170
  • Nevro Corp.$166
  • plus $2K from 26 others

What the payments were for

  • Travel & lodging$2583%
  • Food & beverage$3,90752%
  • Education$3,41745%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,582 in reported general payments places this provider in the 70th percentile of 84 foot & ankle surgery providers in Nevada.

See all foot & ankle surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$245,300
Medicare patients
501
Services billed
4,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl166$1,452
Ciclopirox29$973
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip26$682
Gabapentin19$530
Methylprednisolone61$372
Doxycycline Monohydrate31$296
CiclopiroxCiclopirox Olamine11$280
Allopurinol20$154
Cephalexin13$147
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$136
Amitriptyline Hcl16$104
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$93
Meloxicam12$56

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →